Peanut Hypersensitivity clinical trials
The registry lists 152 studies for Peanut Hypersensitivity across more than 10 countries. 30 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 84
- Recruiting
- 21
- Active, not recruiting
- 12
- Terminated
- 10
- Status unknown
- 9
- Not yet recruiting
- 6
Phase
- Phase 2
- 53
- Phase 1
- 38
- Phase 3
- 19
- Early Phase 1
- 2
- Phase 4
- 1
Where
- United States
- 88
- Canada
- 28
- France
- 18
- United Kingdom
- 15
- Australia
- 13
- Germany
- 12
Who runs them
DBV Technologies (12) · Aimmune Therapeutics, Inc. (10) · University of North Carolina, Chapel Hill (10) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · Johns Hopkins University (7) · Massachusetts General Hospital (5) · Novartis Pharmaceuticals (5) · University Hospital, Montpellier (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 152 — search for more.
- A Randomized Controlled Trial of Oral Immunotherapy Versus Allergen Avoidance in Children Under 2 Years With Food AllergyNot yet recruitingNCT07825662Not applicable1 country
- Efficacy of Tezepelumab in Peanut Oral ImmunotherapyRecruitingNCT07015996Phase 21 country
- A 52-week Study of Remibrutinib in IgE-mediated Food AllergyRecruitingNCT07768371Phase 31 country
- Study of Oral Food Challenge Biomarkers (SAFER)RecruitingNCT072794671 country
- Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic PatientsNot yet recruitingNCT07785063Phase 2
- Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut AllergyRecruitingNCT07287033Phase 11 country
- Flow CAST® Peanut TrialNot yet recruitingNCT07775430
- Multi-Food Oral Immunotherapy for Peanut and Tree NutsNot yet recruitingNCT07764159Not applicable1 country
- Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food AllergyRecruitingNCT07220811Phase 23 countries
- Expecting Mother's Study of Consumption or Avoidance of Peanut and EggRecruitingNCT06260956Not applicable1 country
- Safety of MOON101 for the Treatment of Peanut AllergyRecruitingNCT07580898Phase 11 country
- Single Ascending and Multiple Ascending Dose Study of LCA-0061RecruitingNCT07701954Phase 11 country
- UKK-0018 as an Immunotherapeutic for Treatment of Peanut AllergiesRecruitingNCT07349212Phase 1/22 countries
- Pathway to Peanut ToleranceRecruitingNCT07592780Not applicable1 country
- Predictors of Persistent Peanut Allergy at Age 5 YearsEnrolling by invitationNCT02497261
- Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and SafetyRecruitingNCT06256146Not applicable1 country
- Study of ENP-501 in Peanut-Allergic and Non-Allergic ParticipantsRecruitingNCT07117669Phase 1/21 country
- Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut AllergyNot yet recruitingNCT07439406Phase 21 country
- A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)RecruitingNCT073591831 country
- Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic ChildrenAvailableNCT054247311 country
- Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic PatientsRecruitingNCT05695261Phase 21 country
- Immune-supportive Diet and Gut Permeability in Allergic ChildrenRecruitingNCT05667610Not applicable1 country
- Oral Immunotherapy for Peanut Allergic PatientsRecruitingNCT04163562Phase 1/21 country
- Evaluation of a Supervised Clinical Feeding InterventionNot yet recruitingNCT06892132Not applicable1 country
- EPAP, InterviewstudyRecruitingNCT061929141 country
- TRANS-FOODS: Preventing Peanut Allergy Through Improved Understanding of the Transcutaneous Sensitisation Route, Novel Food Processing and Skin Care AdaptationsRecruitingNCT05407012Not applicable1 country
- Identification of Anaphylactogenic Antibodies in Peanut AllergyEnrolling by invitationNCT02821286
- VE416 for Treatment of Food AllergyRecruitingNCT03936998Phase 1/21 country
- Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral ImmunotherapyRecruitingNCT05163574Not applicable1 country
- Blood Samples for the Study of Peanut, Tree Nut and Other Food AllergiesRecruitingNCT021928661 country
- Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic ParticipantsCompletedNCT03881696Phase 31 country
- Epicutaneous Immunotherapy in Peanut Allergy in ChildrenCompletedNCT01197053Phase 21 country
- Peanut Oral Induction Tolerance in Peanut's Allergic TeenagersCompletedNCT02046083Phase 2/31 country
- Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)Active, not recruitingNCT07003919Phase 38 countries
- A Phase 1 Study of Cizutamig in IgE Mediated DiseasesWithdrawnNCT07408869Phase 11 country
- BÜHLMANN BAT (Basophil Activation Test) in Allergy Diagnosis (Exploratory Pilot Study)CompletedNCT075963031 country
- Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to PeanutsCompletedNCT05432388Phase 21 country
- A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788gCompletedNCT00382148Phase 2
- Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)CompletedNCT03679676Phase 21 country
- Using Commonly Available Food Products To Treat Food AllergyActive, not recruitingNCT05503446Not applicable1 country
- Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut AllergyCompletedNCT05440643Phase 1/22 countries
- PK/PD Study of IN-001 Sublingual Spray in Healthy AdultsCompletedNCT07210320Phase 11 country
- Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic PatientsCompletedNCT02960074Phase 11 country
- Basophil Activation Test (BAT) Sensitivity in Child Food AllergyCompletedNCT01966640Phase 41 country
- Food Oral Immunotherapy for Peanut AllergyActive, not recruitingNCT042224911 country
- Intervention to Reduce Early (Peanut) Allergy in ChildrenCompletedNCT04604431Not applicable1 country
- Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic SubjectsActive, not recruitingNCT05476497Phase 11 country
- Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapyCompletedNCT05138757Phase 1/21 country
- Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of AgeActive, not recruitingNCT05741476Phase 39 countries
- Long-term Extension Study of Ligelizumab in Food AllergyTerminatedNCT05678959Phase 39 countries